glp 1 oral fda approved Wegovy Pill Becomes First GLP-1 Weight-Loss Drug in U.S glp 1 oral fda approved

Cardiovascular outcome trials CVOTs have emerged as a pivotal component of assessing the impact of GLP-1 receptor agonists on cardiovascular health ( GLP-1 receptor agonists have demonstrated unique properties beyond glucose regulation

Assuming you meet the clinical criteria for GLP-1 therapy (BMI of 30+, or 27+ with a related health condition), Hims may be a strong fit depending on your priorities

And that mechanism may help explain some of these curious effects

1017 The ESC guidelines for the management of cardiovascular disease in patients with diabetes recommend GLP1-RAs in patients with T2D and ASCVD to reduce cardiovascular events

Glutathione levels tend to decline with age, and research has suggested a potential link between low glutathione levels and age-related diseases, such as cardiovascular disease, neurodegenerative disorders, and cancer